The Biosimilars Market research report highlights market research and industry analysis driven by in-depth business relevant news. Precision Business Insights has published a report on the global Biosimilars Market, estimating its value at USD 42.8 Billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 18.7% over the forecast period 2025-2031. The report explores...

Precision Business Insights has published a report on the global oncology biosimilars market, estimating its value at USD 32,783.2 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 12.4% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of...

The global Antibodies Market, primarily driven by the therapeutic segment of monoclonal antibodies (mAbs), encompasses highly specific, engineered proteins used to target and neutralize specific cells or proteins in the body. These advanced biopharmaceuticals have revolutionized the treatment of complex diseases by offering high specificity, minimal off-target toxicity, and mechanisms of action...